These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1381615)

  • 1. [Endothelium-derived relaxation factor from vessels--a nitrosyl iron complex with thiol-containing ligands (hypothesis)].
    Vanin AF
    Biofizika; 1992; 37(1):152-7. PubMed ID: 1381615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium-derived relaxing factor is a nitrosyl iron complex with thiol ligands.
    Vanin AF
    FEBS Lett; 1991 Sep; 289(1):1-3. PubMed ID: 1893995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine-induced expression of nitric oxide synthase results in nitrosylation of heme and nonheme iron proteins in vascular smooth muscle cells.
    Geng YJ; Petersson AS; Wennmalm A; Hansson GK
    Exp Cell Res; 1994 Sep; 214(1):418-28. PubMed ID: 7521848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of peroxynitrite and hydrogen peroxide with dinitrosyl iron complexes containing thiol ligands in vitro.
    Lobysheva II; Serezhenkov VA; Vanin AF
    Biochemistry (Mosc); 1999 Feb; 64(2):153-8. PubMed ID: 10187905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Formation of paramagnetic nitrosyl complexes of non heme iron in animals with participation of nitric oxide from exogenous and endogenous sources].
    Mikoian VD; Serezhenkov VA; Brazhnikova NV; Kubrina LN; Khachatrian GN; Vanin AF
    Biofizika; 2004; 49(1):121-7. PubMed ID: 15029727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [From endothelium-derived relaxing factor to L-arginine and nitrogen monoxide].
    Jensen BO; Holmsen H
    Tidsskr Nor Laegeforen; 1992 Aug; 112(19):2531-5. PubMed ID: 1384164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium-derived relaxing factor is a selective relaxant of vascular smooth muscle.
    Shikano K; Berkowitz BA
    J Pharmacol Exp Ther; 1987 Oct; 243(1):55-60. PubMed ID: 3499504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by sulfhydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor.
    Jia L; Furchgott RF
    J Pharmacol Exp Ther; 1993 Oct; 267(1):371-8. PubMed ID: 8229764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the controversy over the identity of EDRF.
    Feelisch M; te Poel M; Zamora R; Deussen A; Moncada S
    Nature; 1994 Mar; 368(6466):62-5. PubMed ID: 8107883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
    Palmer RM; Ferrige AG; Moncada S
    Nature; 1987 Jun 11-17; 327(6122):524-6. PubMed ID: 3495737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelium negatively modulates the vascular relaxation induced by nitric oxide donor, due to uncoupling NO synthase.
    Bonaventura D; Lunardi CN; Rodrigues GJ; Neto MA; Vercesi JA; de Lima RG; da Silva RS; Bendhack LM
    J Inorg Biochem; 2009 Oct; 103(10):1366-74. PubMed ID: 19699534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction and vascular disease.
    Vanhoutte PM
    Verh K Acad Geneeskd Belg; 1998; 60(3):251-66. PubMed ID: 9803882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor.
    Gryglewski RJ; Palmer RM; Moncada S
    Nature; 1986 Apr 3-9; 320(6061):454-6. PubMed ID: 3007998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of endothelial nitric oxide synthase by ebselen. Prevention by thiols suggests the inactivation by ebselen of a critical thiol essential for the catalytic activity of nitric oxide synthase.
    Zembowicz A; Hatchett RJ; Radziszewski W; Gryglewski RJ
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1112-8. PubMed ID: 7505326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction to EDRF research.
    Furchgott RF
    J Cardiovasc Pharmacol; 1993; 22 Suppl 7():S1-2. PubMed ID: 7504760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first structurally characterized nitrosyl heme thiolate model complex.
    Xu N; Powell DR; Cheng L; Richter-Addo GB
    Chem Commun (Camb); 2006 May; (19):2030-2. PubMed ID: 16767265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible nitric oxide synthase in vascular smooth muscle.
    Schini VB; Busse R; Vanhoutte PM
    Arzneimittelforschung; 1994 Mar; 44(3A):432-5. PubMed ID: 7514415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autowave mode of functioning of the system nitric oxide + free iron + thiols may ensure the regulation of biological action of nitric oxide and its endogenic compounds].
    Vanin AF
    Biofizika; 2006; 51(6):965-7. PubMed ID: 17175906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current knowledge on the formation of nitric oxide in endothelial cells of blood vessels, in nerve cells and macrophages as well as its significance in vascular dilatation, information transmission and damage of tumor cells].
    Kolb E
    Z Gesamte Inn Med; 1991 Aug; 46(12):431-6. PubMed ID: 1719706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-arginine, but not N alpha-benzoyl-L-arginine ethyl ester, is a precursor of endothelium-derived relaxing factor.
    Fasehun OA; Gross SS; Rubin LE; Jaffe EA; Griffith OW; Levi R
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1348-53. PubMed ID: 2175803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.